When Biology and High Tech Collide: Strategies for Protecting IP in Emerging Medical and Life Science Technologies (On Demand)

By in-house counsel, for in-house counsel ^®

ACC Members

Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

Available On-Demand - Publication Date: 05/29/2024

60 minutes

Overview (Program Summary)

A program hosted by:

ACC San Francisco Bay Area

This program originally aired on March 20, 2024. Please note that this program recording is not eligible for CLE/CPD credit.

Presented by:

Emily Gardel, Ph.D., J.D.
Associate Director, Patent Attorney II
Dyno Therapeutics

Sylvia Georges Evangelinos, Ph.D., J.D.
Head R&D IP for Neuroscience and Discovery Sciences
Novartis

Leslie Grab, Ph.D., J.D.
Vice President, Corporate Legal
BigHat Biosciences

Aaron Capron
Partner
Finnegan

Jeffrey Smyth
Partner
Finnegan

Search

When Biology and High Tech Collide: Strategies for Protecting IP in Emerging Medical and Life Science Technologies (On Demand)

Overview (Program Summary)